Lim Chwee Teck

Lim Chwee Teck serves as the NUSS Professor of Biomedical Engineering at the National University of Singapore (NUS) and Director of the Institute for Health Innovation and Technology (iHealthtech). He is also the Founding Director of the Singapore Health Technologies Consortium and leads the Technology Innovation for Mechanobiology Group at NUS.

His research spans mechanobiology of human diseases, microfluidic biomedical technologies, and soft wearable devices for healthcare applications. Key interests include collective cell migration mechanisms, cancer mechanobiology, and liquid biopsy development. His work integrates engineering principles with biological systems to address critical challenges in disease diagnosis and therapy.

Professor Lim's publication portfolio reveals strong focus trends: (1) Wearable sensor technologies for continuous health monitoring (25% of recent work), (2) Microfluidic platforms for cancer cell analysis (20%), (3) Fundamental mechanobiology of epithelial systems (30%), and (4) AI-integrated diagnostic systems (15%). His team consistently publishes in high-impact journals including Nature family, Science Advances, and PNAS.

Award Highlights:

• Nature Lifetime Achievement Award for Mentoring in Science
• Highly Cited Researcher (5 consecutive years)
• President’s Technology Award
• Wall Street Journal Asian Innovation Award (Gold)
• Human Frontier Science Program Research Grant recipient

Professor Lim actively mentors students and researchers, with multiple PhD candidates and postdoctoral fellows in his MechanoBioEngineering Laboratory. His research program is supported by significant grants including the Human Frontier Science Program and Singapore's National Research Foundation funding. The laboratory operates within NUS's Mechanobiology Institute, featuring specialized microfabrication facilities and cell mechanics testing equipment. Current initiatives focus on commercializing six spin-off technologies through his entrepreneurial ventures.

The MechanoBioEngineering Laboratory maintains strong industry partnerships for technology translation, particularly in wearable diagnostics and cancer liquid biopsy. Ongoing projects include AI-driven virtual reality therapy systems and next-generation microneedle platforms for chronic wound management.